[
  {
    "ts": "2026-01-20T16:02:48+00:00",
    "headline": "Jim Cramer on Intuitive Surgical: “One day, These Upside Surprises Will Come to an End”",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? I think that the lone surprise blowout next week will come from Intuitive Surgical, which had a monster quarter last time. But I bet that […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-intuitive-surgical-one-160248249.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "750c0f0a-3dbf-3c3e-bc32-faf0b294d9de",
      "content": {
        "id": "750c0f0a-3dbf-3c3e-bc32-faf0b294d9de",
        "contentType": "STORY",
        "title": "Jim Cramer on Intuitive Surgical: “One day, These Upside Surprises Will Come to an End”",
        "description": "",
        "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? I think that the lone surprise blowout next week will come from Intuitive Surgical, which had a monster quarter last time. But I bet that […]",
        "pubDate": "2026-01-20T16:02:48Z",
        "displayTime": "2026-01-20T16:02:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/c517b12f3958826ffde57cfe2fa1093a",
          "originalWidth": 3000,
          "originalHeight": 2001,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/brs9lzIYqg.kElTS8kumAw--~B/aD0yMDAxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/c517b12f3958826ffde57cfe2fa1093a.cf.webp",
              "width": 3000,
              "height": 2001,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UNpecKjURi_t1ksuePcCHQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/c517b12f3958826ffde57cfe2fa1093a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-intuitive-surgical-one-160248249.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-intuitive-surgical-one-160248249.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T15:37:00+00:00",
    "headline": "Robotic surgery fuels Johnson & Johnson dividend growth outlook",
    "summary": "Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification. That's a big deal because it marks J&J's formal entry into the fast-growing robotic ...",
    "url": "https://www.thestreet.com/investing/stocks/robotic-surgery-fuels-johnson-johnson-dividend-growth-outlook",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "aa14054a-c00e-39b8-9f1c-2345b4ecc10f",
      "content": {
        "id": "aa14054a-c00e-39b8-9f1c-2345b4ecc10f",
        "contentType": "STORY",
        "title": "Robotic surgery fuels Johnson & Johnson dividend growth outlook",
        "description": "",
        "summary": "Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification. That's a big deal because it marks J&J's formal entry into the fast-growing robotic ...",
        "pubDate": "2026-01-20T15:37:00Z",
        "displayTime": "2026-01-20T15:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/2f5726b2398d5b3a9b4234511887913d",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6Q6eAkXR79TE2.yGrcaGSA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/2f5726b2398d5b3a9b4234511887913d.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YvYl3ATksv9SVEQQG04Rhg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/2f5726b2398d5b3a9b4234511887913d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/investing/stocks/robotic-surgery-fuels-johnson-johnson-dividend-growth-outlook",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/robotic-surgery-fuels-johnson-johnson-153700279.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ISRG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T18:39:00+00:00",
    "headline": "Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?",
    "summary": "ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.",
    "url": "https://finance.yahoo.com/news/intuitive-surgical-pre-q4-analysis-183900455.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "dd625b0c-b5db-34eb-a285-4bfad5483e22",
      "content": {
        "id": "dd625b0c-b5db-34eb-a285-4bfad5483e22",
        "contentType": "STORY",
        "title": "Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?",
        "description": "",
        "summary": "ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.",
        "pubDate": "2026-01-20T18:39:00Z",
        "displayTime": "2026-01-20T18:39:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ly2eKWIt2DGVNvSZ_c1.OQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jcy0r8Ec0Arq0Msc4P7F2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ffe56c6b40972cd987bbb0cf256ae119.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-surgical-pre-q4-analysis-183900455.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-surgical-pre-q4-analysis-183900455.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]